Related Articles
Toxicity of adjuvant high-dose interferon-alpha-2b in patients with cutaneous melanoma at high risk of recurrence.
Secondary erythromelalgia successfully treated with patient‑controlled epidural analgesia and interferon α‑2b: A case report and review of the literature
3-year treatment with recombinant interferon-alpha as adjuvant therapy of cutaneous malignant melanoma.
Rare incidence of a diffuse brain metastatic carcinoma: A case report
Interleukin-2 and interferon alpha 2 combination